Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2024
Werte in diesem Artikel
WARSAW, Ind., Dec. 18, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the fourth quarter of 2024. The cash dividend of $0.24 per share is payable on or about January 31, 2025 to stockholders of record as of the close of business on December 30, 2024.
About Zimmer Biomet
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.
With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.
For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow on LinkedIn at www.linkedin.com/company/zimmerbiomet or X / Twitter at www.twitter.com/zimmerbiomet.
Media | Investors |
Heather Zoumas-Lubeski | David DeMartino |
445-248-0577 | 646-531-6115 |
Zach Weiner | |
908-591-6955 | |
View original content to download multimedia:https://www.prnewswire.com/news-releases/zimmer-biomet-announces-quarterly-dividend-for-fourth-quarter-of-2024-302334477.html
SOURCE Zimmer Biomet Holdings, Inc.
Ausgewählte Hebelprodukte auf Zimmer Biomet
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Zimmer Biomet
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu Zimmer Biomet
Analysen zu Zimmer Biomet
Datum | Rating | Analyst | |
---|---|---|---|
30.07.2019 | Zimmer Biomet Equal Weight | Barclays Capital | |
24.04.2019 | Zimmer Biomet Strong Buy | Needham & Company, LLC | |
03.01.2019 | Zimmer Biomet Hold | Deutsche Bank AG | |
16.10.2018 | Zimmer Biomet Underweight | Barclays Capital | |
16.08.2018 | Zimmer Biomet Neutral | BTIG Research |
Datum | Rating | Analyst | |
---|---|---|---|
24.04.2019 | Zimmer Biomet Strong Buy | Needham & Company, LLC | |
13.08.2018 | Zimmer Biomet Buy | Needham & Company, LLC | |
30.07.2018 | Zimmer Biomet Strong Buy | Needham & Company, LLC | |
27.04.2018 | Zimmer Biomet Strong Buy | Needham & Company, LLC | |
31.01.2018 | Zimmer Biomet Buy | Stifel, Nicolaus & Co., Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
30.07.2019 | Zimmer Biomet Equal Weight | Barclays Capital | |
03.01.2019 | Zimmer Biomet Hold | Deutsche Bank AG | |
16.08.2018 | Zimmer Biomet Neutral | BTIG Research | |
30.06.2017 | Zimmer Biomet Neutral | Cantor Fitzgerald | |
04.03.2016 | Zimmer Hold | Argus Research Company |
Datum | Rating | Analyst | |
---|---|---|---|
16.10.2018 | Zimmer Biomet Underweight | Barclays Capital | |
05.10.2011 | Zimmer sell | Citigroup Corp. | |
24.07.2008 | Zimmer Holdings underperform | Credit Suisse Group | |
08.11.2007 | Zimmer Holdings underperform | Credit Suisse Group | |
28.09.2005 | Update Zimmer Holdings Inc.: Market Underperform | JMP Securities |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Zimmer Biomet nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen